• Invest
    Investment Suite
    Stocks
    Mutual Funds
    Future and Options
    IPO
    Exchange Traded Funds
    Commodity
    Stockcase (Stock Baskets)
    Currency
    Non Convertible Debentures
    Sovereign Gold Bond
    Exclusive
    NRI Account
    Corporate/HUF Trading Account
    Private Client Group
    Features
    SipIt
    MTF
    Investment Suite
    Exclusive
    Features
  • Platform
    Product Suite
    Kotak Neo App & Web
    Nest Trading Terminal
    NEO Trade APIs
    Features and Tools
    MTF
    Securities Accepted as Collateral
    Margin Requirements
    Equity Screeners
    Payoff Analyzer
    Calculators
    SIP Calculator
    Lumpsum Calculator
    Brokerage Calculator
    Margin Calculator
    MTF Calculator
    SWP Calculator
    CAGR Calculator
    Simple Interest Calculator
    ELSS Calculator
    Step up SIP Calculator
    All Calculators
    Product Suite
    Features and Tools
    Calculators
  • Pricing
  • Research
    Research Calls
    Long Term calls
    Short Term calls
    Intraday calls
    Derivatives calls
    Pick of the week
    Top Monthly Picks
    Research Reports
    Fundamental Research Report
    Technical Research Report
    Derivative Research Report
    Research Calls
    Research Reports
  • Market
    Stocks
    Share Market Today
    Large Cap
    Mid Cap
    Small Cap
    Indices
    Nifty 50
    Bank Nifty
    FinNifty
    Nifty Midcap India
    VIX
    All Indian Indices
    Mutual Funds
    SBI Mutual Funds
    HDFC Mutual Funds
    Axis Mutual Funds
    ICICI Prudential Mutual Funds
    Nippon India Mutual Funds
    All AMC's
    IPO
    Upcoming IPO
    Current IPO
    Closed IPO
    Recently Listed IPO
    Stocks
    Indices
    Mutual Funds
    IPO
  • Learn
    Resource
    Market Ready
    Kotak Insights
    Infographic
    Podcast
    Webinars
    Youtube Channel
    Quarterly Results
    Investing Guide
    Demat Account
    Trading Account
    Share Market
    Intraday Trading
    IPO
    Mutual Funds
    Commodities
    Currency
    Futures & Options
    Derivatives
    Margin Trading
    Events
    Budget 2025
    Muhurat Trading
    Share Market Holiday
    Market Outlook 2025
    Resource
    Investing Guide
    Events
  • Partner
    Business Associates
    Kotak Connect Plus
    Startup connect
  • Support
    FAQs
    Circulars
    Bulletins
    Contact Us
    Forms Download
    Get your Statement
​

Metropolis Healthcare Ltd's Q3FY25 Quarter Results

Metropolis Healthcare Ltd's revenue increased 10.9% YoY
  • 05 Feb 2025
  • Metropolis Healthcare Ltd reported a 7.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 10.9%.
  • Its expenses for the quarter were down by 2.9% QoQ and up 10.3% YoY.
  • The net profit decreased 32.6% QoQ and increased 15.3% YoY.
  • The earnings per share (EPS) of Metropolis Healthcare Ltd stood at 6.1 during Q3FY25.
(₹ crores) Q3FY25 Q2FY25 Q3FY24 QoQ (%) YoY (%)
Total Income
325.32
352.92
293.42
-7.8%
10.9%
Total Expenses
282.99
291.52
256.57
-2.9%
10.3%
Profit Before Tax
42.34
61.40
36.85
-31.0%
14.9%
Tax
10.86
14.70
9.57
-26.1%
13.5%
Profit After Tax
31.47
46.70
27.29
-32.6%
15.3%
Earnings Per Share
6.10
9.00
5.30
-32.2%
15.1%

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Metropolis Healthcare Ltd is a leading diagnostic company in India, primarily engaged in providing pathology and diagnostic services. The company operates in the healthcare sector, which is a crucial industry supporting public health through medical testing and diagnostics. Metropolis Healthcare has a network of diagnostic laboratories and collection centers across various locations, which facilitates a wide range of pathology tests and health check-ups. The company is known for its focus on quality and reliability of test results, catering to the needs of hospitals, laboratories, and individual patients. As of the most recent updates, there are no specific major developments available for Metropolis Healthcare Ltd beyond its ongoing operations and market presence.

In Q3FY25, Metropolis Healthcare Ltd reported a total income of ₹325.32 crores. This represents a decrease of 7.8% on a quarter-over-quarter (QoQ) basis from ₹352.92 crores in Q2FY25. However, when compared to the same quarter of the previous financial year, Q3FY24, there is a year-over-year (YoY) increase of 10.9% from ₹293.42 crores. The YoY growth indicates an increase in revenue generation over the past year, despite the recent QoQ decline. The revenue performance is a critical indicator of the company's ability to maintain its market share and expand in the diagnostic services sector.

Metropolis Healthcare Ltd's profitability metrics for Q3FY25 show a profit before tax (PBT) of ₹42.34 crores, which is a 31.0% decline QoQ from ₹61.40 crores in Q2FY25. Compared to Q3FY24, there is a YoY increase of 14.9% from ₹36.85 crores. The tax expense for Q3FY25 was ₹10.86 crores, down by 26.1% QoQ from ₹14.70 crores in Q2FY25, and up by 13.5% YoY from ₹9.57 crores. Profit after tax (PAT) for Q3FY25 amounted to ₹31.47 crores, marking a 32.6% decrease from the previous quarter's ₹46.70 crores. However, it represents a 15.3% increase from Q3FY24, where the PAT was ₹27.29 crores. The earnings per share (EPS) for the quarter was ₹6.10, down 32.2% QoQ from ₹9.00, but up 15.1% YoY from ₹5.30. These figures reflect the company's profit margins and tax efficiencies over the specified periods.

The operating metrics for Metropolis Healthcare Ltd in Q3FY25 include total expenses amounting to ₹282.99 crores, which shows a decrease of 2.9% QoQ from ₹291.52 crores in Q2FY25. Comparing YoY, there is an increase of 10.3% from ₹256.57 crores in Q3FY24. These operating expenses highlight the cost structure and spending efficiency of the company during the period. The decrease in expenses QoQ, despite the reduction in total income, demonstrates the company's operational adjustments. Additionally, the YoY increase in expenses is aligned with the YoY increase in total income, suggesting consistent operational scaling. The analysis of these metrics provides insights into the company’s cost management and efficiency in resource allocation.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -

​N
​N
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]